However, every journey is unique, and the results can hence differ from person to person
Glucagon receptor-mediated hepatic fat mobilisation is the mechanistic differentiator from GLP-1/GIP compounds in this indication
Secondary efficacy measures included changes from baseline in: fast plasma glucose (FPG), postprandial plasma glucose (PPG), area under the curve, insulin, C-peptide, glucagon, insulin/proinsulin ratio, body measurements, and fasting lipid profiles
Sprinkle the feta evenly over the tops of the cups
For first-time users: Start with a dose of 2.5mg
The prodrug strategy using phosphoramidates to enable oral delivery of nucleoside analogs was known in the literature